SLC35G5

Across TCGA pan-cancer cohorts, SLC35G5 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of SLC35G5’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where SLC35G5 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SLC35G5 is over-expressed in tumor, although a few such as COAD show the opposite, repressed pattern.

HNSC, STAD, and CHOL are the cancer types where SLC35G5 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SLC35G5 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+0.295	.004	4	view →
STAD	All	All	+0.270	.011	4	view →
CHOL	All	All	+0.375	.015	2	view →
COAD	All	III,IV	−0.113	.002	2	view →
LIHC	Male	All	+0.036	.044	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

SLC35G5–HNSC

Open the HNSC breakdown →